Is there a relationship between serum paraoxonase level and epicardial fat tissue thickness?

Anadolu Kardiyoloji Dergisi

Volumn 14, Issue 2, 2014, Pages 115-120

  Ertem, Ahmet Göktuď ^a   Erayman, Ali ^b   Efe, Tolga Han ^c   Karaduman, Bilge Duran ^d   Aydin, Halil Ibrahim ^e   Bilge, Mehmet ^d  

^a Ankara Penal Institution Campus State Hospital   (Turkey)

^b Eye Clinic Pazarcik   (Turkey)

^c Mus State Hospital   (Turkey)

^d ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^e FATIH UNIVERSITY   (Turkey)

Author keywords

Echocardiography; Epicardial fat tissue; Serum paraoxonase 1 level

Indexed keywords

4 NITROPHENOL; ARYLDIALKYLPHOSPHATASE 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ARYLDIALKYLPHOSPHATASE;

ADIPOSE TISSUE; ADULT; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; EPICARDIAL FAT TISSUE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBSERVATION; THROMBOCYTE COUNT; TRANSTHORACIC ECHOCARDIOGRAPHY; TRIACYLGLYCEROL BLOOD LEVEL; VEIN PUNCTURE; BLOOD; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; ECHOGRAPHY; MIDDLE AGED; PERICARDIUM;

ADIPOSE TISSUE; ARYLDIALKYLPHOSPHATASE; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PERICARDIUM;

EID: 84897391083     PISSN: None     EISSN: 13080032     Source Type: Journal    
DOI: 10.5152/akd.2014.4742     Document Type: Article

References (46)

1. Ross R. Atherosclerosis -an inflammatory disease. N Engl J Med 1999; 340: 115-26. [CrossRef]
2. Bonthu S, Heistad DD, Chappell DA, Lamping KG, Faraci FM. Atherosclerosis, vascular remodeling, and impairment of endotheliumdependent relaxation in genetically altered hyperlipidemic mice. Arterioscler Thromb Vasc Biol 1997; 17: 2333-40. [CrossRef]
3. Deckert V, Lizard G, Duverger N, Athias A, Palleau V, Emmanuel F, et al. Impairment of endothelium-dependent arterial relaxation by high-fat feeding in ApoE-deficient mice: toward normalization by human ApoA-I expression. Circulation 1999; 100: 1230-5. [CrossRef]
4. Zamboni M, Armellini F, Sheiban I, De Marchi M, Todesco T, Bergamo Andreis IA, et al. Relation of body fat distribution in men and degree of coronary narrowings in coronary artery disease. Am J Cardiol 1992; 70: 1135-8. [CrossRef]
5. Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E, Sjostrom L. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J (Clin Res Ed) 1984; 289: 1257-61. [CrossRef]
6. Rexrode KM, Carey VJ, Hennekens CH, Walters EE, Colditz GA, Stampfer MJ, et al. Abdominal adiposity and coronary heart disease in women. JAMA 1998; 280: 1843-8. [CrossRef]
7. Rexrode KM, Buring JE, Manson JE. Abdominal and total adiposity and risk of coronary heart disease in men. Int J Obes Relat Metab Disord 2001; 25: 1047-56. [CrossRef]
8. de Koning L, Merchant AT, Pogue J, Anand SS. Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: metaregression analysis of prospective studies. Eur Heart J 2007; 28: 850-6. [CrossRef]
9. Graner M, James RW, Kahri J, Nieminen MS, Syvanne M, Taskinen MR. Association of paraoxonase-1 activity and concentration with angiographic severity and extent of coronary artery disease. J Am Coll Cardiol 2006; 47: 2429-35. [CrossRef]
10. Iacobellis G, Assael F, Ribaudo MC, Zappaterreno A, Alessi G, Di Mario U, et al. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res 2003; 11: 304-10. [CrossRef]
11. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation 2004; 109: 433-8. [CrossRef]
12. Iacobellis G, Willens HJ, Barbaro G, Sharma AM. Threshold values of high-risk echocardiographic epicardial fat thickness. Obesity 2008; 16: 887-92. [CrossRef]
13. Mariani S, Fiore D, Barbaro G, Basciani S, Saponara M, D'Arcangelo E, et al. Association of epicardial fat thickness with the severity of obstructive sleep apnea in obese patients. Int J Cardiol 2013; 167: 2244-9. [CrossRef]
14. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937-52. [CrossRef]
15. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007; 116: 39-48. [CrossRef]
16. Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003; 108: 2460-6. [CrossRef]
17. Baker AR, Silva NF, Quinn DW, Harte AL, Pagano D, Bonser RS, et al. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol 2006; 5: 1. [CrossRef]
18. Chaldakov GN, Fiore M, Stankulov IS, Manni L, Hristova MG, Antonelli A, et al. Neurotrophin presence in human coronary atherosclerosis and metabolic syndrome: a role for NGF and BDNF in cardiovascular disease? Prog Brain Res 2004; 146: 279-89. [CrossRef]
19. Kremen J, Dolinkova M, Krajickova J, Blaha J, Anderlova K, Lacinova Z, et al. Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance. J Clin Endocrinol Metab 2006; 91: 4620-7. [CrossRef]
20. Cheng KH, Chu CS, Lee KT, Lin TH, Hsieh CC, Chiu CC, et al. Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease. Int J Obes (Lond) 2008; 32: 268-74. [CrossRef]
21. Fain JN, Sacks HS, Buehrer B, Bahouth SW, Garrett E, Wolf RY, et al. Identification of omentin mRNA in human epicardial adipose tissue: comparison to omentin in subcutaneous, internal mammary artery periadventitial and visceral abdominal depots. Int J Obes (Lond) 2008; 32: 810-5. [CrossRef]
22. Sade LE, Eroǧlu S, Bozbaş H, Ozbicer S, Hayran M, Haberal A, et al. Relation between epicardial fat thickness and coronary flow reserve in women with chest pain and angiographically normal coronary arteries. Atherosclerosis 2009; 204: 580-5. [CrossRef]
23. Jeong JW, Jeong MH, Yun KH, Oh SK, Park EM, Kim YK, et al. Echocardiographic epicardial fat thickness and coronary artery disease. Circ J 2007; 71: 536-9. [CrossRef]
24. Ahn SG, Lim HS, Joe DY, Kang SJ, Choi BJ, Choi SY, et al. Relationship of epicardial adipose tissue by echocardiography to coronary artery disease. Heart 2008; 94: 7. [CrossRef]
25. Eroǧlu S, Sade LE, Yildirir A, Bal U, Ozbicer S, Ozgul AS, et al. Epicardial adipose tissue thickness by echocardiography is a marker for the presence and severity of coronary artery disease. Nutr Metab Cardiovasc Dis 2009; 19: 211-7. [CrossRef]
26. Gorter PM, de Vos AM, van der Graaf Y, Stella PR, Doevendans PA, Meijs MF, et al. Relation of epicardial and pericoronary fat to coronary atherosclerosis and coronary artery calcium in patients undergoing coronary angiography. Am J Cardiol 2008; 102: 380-5. [CrossRef]
27. Iacobellis G, Leonetti F. Epicardial adipose tissue and insulin resistance in obese subjects. J Clin Endocrinol Metab 2005; 90: 6300-2. [CrossRef]
28. Natale F, Tedesco MA, Mocerino R, de Simone V, Di Marco GM, Aronne L, et al. Visceral adiposity and arterial stiffness: echocardiographic epicardial fat thickness respects, better than waist circumference, carotid arterial stiffness in a large population of hypertensives. Eur J Echocardiogr 2009; 10: 549-55. [CrossRef]
29. Iacobellis G, Barbaro G, Gerstein HC. Relationship of epicardial fat thickness and fasting glucose. Int J Cardiol 2008; 128: 424-6. [CrossRef]
30. Malavazos AE, Ermetici F, Cereda E, Coman C, Locati M, Morricone L, et al. Epicardial fat thickness: relationship with plasma visfatin and plasminogen activator inhibitor-1 levels in visceral obesity. Nutr Metab Cardiovasc Dis 2008; 18: 523-30. [CrossRef]
31. Iacobellis G, Pellicelli AM, Grisorio B, Barbarini G, Leonetti F, Sharma AM, et al. Relation of epicardial fat and alanine aminotransferase in subjects with increased visceral fat. Obesity (Silver Spring) 2008; 16: 179-83. [CrossRef]
32. Yun KH, Rhee SJ, Yoo NJ, Oh SK, Kim NH, Jeong JW, et al. Relationship between the echocardiographic epicardial adipose tissue thickness and serum adiponectin in patients with angina. J Cardiovasc Ultrasound 2009; 17: 121-6. [CrossRef]
33. de Vos AM, Prokop M, Roos CJ, Meijs MF, van der Schouw YT, Rutten A, et al. Peri-coronary epicardial adipose tissue is related to cardiovascular risk factors and coronary artery calcification in post-menopausal women. Eur Heart J 2008; 29: 777-83. [CrossRef]
34. Ahmadi N, Nabavi V, Yang E, Hajsadeghi F, Lakis M, Flores F, et al. Increased epicardial, pericardial, and subcutaneous adipose tissue is associated with the presence and severity of coronary artery calcium. Acad radiol 2010; 17: 1518-24. [CrossRef]
35. Alexopoulos N, McLean DS, Janik M, Arepalli CD, Stillman AE, Raggi P. Epicardial adipose tissue and coronary artery plaque characteristics. Atherosclerosis 2010; 210: 150-4. [CrossRef]
36. Djaberi R, Schuijf JD, van Werkhoven JM, Nucifora G, Jukema JW, Bax JJ. Relation of epicardial adipose tissue to coronary atherosclerosis. Am J Cardiol 2008; 102: 1602-7. [CrossRef]
37. Bucci M, Joutsiniemi E, Saraste A, Kajander S, Ukkonen H, Saraste M, et al. Intrapericardial, but not extrapericardial, fat is an independent predictor of impaired hyperemic coronary perfusion in coronary artery disease. Arterioscler Thromb Vasc Biol 2011; 31: 211-8. [CrossRef]
38. Iacobellis G. Relation of epicardial fat thickness to right ventricular cavity size in obese subjects. Am J Cardiol 2009; 104: 1601-2. [CrossRef]
39. Tavori H, Aviram M, Khatib S, Musa R, Nitecki S, Hoffman A, et al. Human carotid atherosclerotic plaque increases oxidative state of macrophages and low-density lipoproteins, whereas paraoxonase 1 (PON1) decreases such atherogenic effects. Free Radic Biol Med 2009; 46: 607-15. [CrossRef]
40. Moren X, Deakin S, Liu ML, Taskinen MR, James RW. HDL subfraction distribution of paraoxonase-1 and its relevance to enzyme activity and resistance to oxidative stress. J Lipid Res 2008; 49: 1246-53. [CrossRef]
41. Leus FR, Wittekoek ME, Prins J, Kastelein JJ, Voorbij HA. Paraoxonase gene polymorphisms are associated with carotid arterial wall thickness in subjects with familial hypercholesterolemia. Atherosclerosis 2000; 149: 371-7 [CrossRef]
42. Zama T, Murata M, Matsubara Y, Kawano K, Aoki N, Yoshino H, et al. A 192Arg variant of the human paraoxonase (HUMPONA) gene polymorphism is associated with an increased risk for coronary artery disease in the Japanese. Arterioscler Thromb Vasc Biol 1997; 17: 3565-9. [CrossRef]
43. Iacobellis G, Willens HJ. Echocardiographic epicardial fat: a review of research and clinical applications. J Am Soc Echocardiogr 2009; 22: 1311-9. [CrossRef]
44. Tansey DK, Aly Z, Sheppard MN. Fat in the right ventricle of the normal heart. Histopathology 2005; 46: 98-104. [CrossRef]
45. Sironi AM, Pingitore A, Ghione S, De Marchi D, Scattini B, Positano V, et al. Early hypertension is associated with reduced regional cardiac function, insulin resistance, epicardial, and visceral fat. Hypertension 2008; 51: 282-8. [CrossRef]
46. Aydoǧdu A, Uckaya G, Taşci I, Baysan O, Tapan S, Bugan B, et al. The relationship of epicardial adipose tissue thickness to clinical and biochemical features in women with polycystic ovary syndrome. Endocr J 2012; 59: 509-161 [CrossRef]